Literature DB >> 2789942

Non-ocular cancer in relatives of retinoblastoma patients.

B M Sanders1, M Jay, G J Draper, E M Roberts.   

Abstract

A series of 1,438 parents and 2,663 other relatives of retinoblastoma patients have been followed up to ascertain the incidence among them of non-ocular cancer. Among 117 of these relatives who were known carriers of the mutation of the retinoblastoma gene 23 cases of non-ocular cancer developed during the follow-up period of the study. This compares with an expected number of 2.3, a relative risk of 9.9. A total of 25 deaths among these carriers included 21 from non-ocular cancer; the expected number was 1.8, a relative risk of 11.6. Relatives who are carriers are about 15 times more likely to die from lung cancer than the general population. Previous findings of an association of melanoma and bladder cancer with retinoblastoma are borne out in this study. The incidence of non-ocular cancer among relatives of hereditary cases who are not definitely known to be carriers shows an excess risk of 1.6: it is concluded that a proportion of these relatives are in fact carriers of the mutated retinoblastoma gene. For relatives who are not gene carriers there appears to be no excess risk of developing cancer. Carriers relatives who are not themselves affected with retinoblastoma may be inherently less liable than affected carriers to the further genetic changes which lead to the development of both retinoblastoma and subsequent non-ocular cancer.

Entities:  

Mesh:

Year:  1989        PMID: 2789942      PMCID: PMC2247167          DOI: 10.1038/bjc.1989.285

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Cohort study analysis with a FORTRAN computer program.

Authors:  M Coleman; A Douglas; C Hermon; J Peto
Journal:  Int J Epidemiol       Date:  1986-03       Impact factor: 7.196

2.  Family studies in retinoblastoma.

Authors:  H Gordon
Journal:  Birth Defects Orig Artic Ser       Date:  1974

3.  Hereditary retinoblastoma: delayed mutation or host resistance?

Authors:  E Matsunaga
Journal:  Am J Hum Genet       Date:  1978-07       Impact factor: 11.025

4.  Incidence of cancer in relatives of children with retinoblastoma.

Authors:  J Fedrick; J A Baldwin
Journal:  Br Med J       Date:  1978-01-14

5.  Retinoblastoma: a prototypic hereditary neoplasm.

Authors:  A G Knudson
Journal:  Semin Oncol       Date:  1978-03       Impact factor: 4.929

Review 6.  Retinoblastoma: clues to human oncogenesis.

Authors:  A L Murphree; W F Benedict
Journal:  Science       Date:  1984-03-09       Impact factor: 47.728

7.  Cancer mortality in relatives of retinoblastoma patients.

Authors:  L C Strong; J Herson; C Haas; K Elder; R Chakraborty; K M Weiss; P Majumder
Journal:  J Natl Cancer Inst       Date:  1984-08       Impact factor: 13.506

8.  Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced?

Authors:  D H Abramson; R M Ellsworth; F D Kitchin; G Tung
Journal:  Ophthalmology       Date:  1984-11       Impact factor: 12.079

9.  Excess of cancer deaths in grandparents of patients with retinoblastoma.

Authors:  C Bonaïti-Pellié; M L Briard-Guillemot
Journal:  J Med Genet       Date:  1980-04       Impact factor: 6.318

10.  Excess of cancer deaths in close relatives of patients with bilateral retinoblastoma.

Authors:  A Tarkkanen; K Karjalainen
Journal:  Ophthalmologica       Date:  1984       Impact factor: 3.250

View more
  21 in total

Review 1.  Molecular genetic abnormalities in the pathogenesis of human lung cancer.

Authors:  E Forgacs; S Zöchbauer-Müller; E Oláh; J D Minna
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 2.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

3.  Variants in the GH-IGF axis confer susceptibility to lung cancer.

Authors:  Matthew F Rudd; Emily L Webb; Athena Matakidou; Gabrielle S Sellick; Richard D Williams; Helen Bridle; Tim Eisen; Richard S Houlston
Journal:  Genome Res       Date:  2006-06       Impact factor: 9.043

4.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

Authors:  Christopher I Amos; Xifeng Wu; Peter Broderick; Ivan P Gorlov; Jian Gu; Timothy Eisen; Qiong Dong; Qing Zhang; Xiangjun Gu; Jayaram Vijayakrishnan; Kate Sullivan; Athena Matakidou; Yufei Wang; Gordon Mills; Kimberly Doheny; Ya-Yu Tsai; Wei Vivien Chen; Sanjay Shete; Margaret R Spitz; Richard S Houlston
Journal:  Nat Genet       Date:  2008-04-02       Impact factor: 38.330

5.  Application of intragenic DNA probes in prenatal screening for retinoblastoma gene carriers in the United Kingdom.

Authors:  Z O Onadim; C D Mitchell; P C Rutland; B G Buckle; M Jay; J L Hungerford; K Harper; J K Cowell
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

Review 6.  Role of the retinoblastoma gene in the initiation and progression of human cancer.

Authors:  W F Benedict; H J Xu; S X Hu; R Takahashi
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

7.  Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis.

Authors:  David S Simpson; Nicole A Mason-Richie; Caitlin A Gettler; Kathryn A Wikenheiser-Brokamp
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

8.  Association between CLPTM1L polymorphisms (rs402710 and rs401681) and lung cancer susceptibility: evidence from 27 case-control studies.

Authors:  De-ping Zhao; Chen-lu Yang; Xiao Zhou; Jia-an Ding; Ge-ning Jiang
Journal:  Mol Genet Genomics       Date:  2014-06-07       Impact factor: 3.291

Review 9.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

Review 10.  Familial and genetic risk of transitional cell carcinoma of the urinary tract.

Authors:  Christine M Mueller; Neil Caporaso; Mark H Greene
Journal:  Urol Oncol       Date:  2008-06-18       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.